During a routine surgical procedure, a 28-year-old female patient receives a non-depolarising muscle relaxant for intraoperative neuromuscular blockade. Which of the following is the most common route of elimination for non-depolarising muscle relaxants?

Explanation

## Routes of Elimination of Non-Depolarising Muscle Relaxants **Key Point:** Renal excretion is the most common route of elimination for the majority of non-depolarising muscle relaxants, accounting for 60–90% of drug clearance in most agents. ### Classification by Elimination Route | Agent | Primary Route | Secondary Route | Clinical Implication | |---|---|---|---| | **Vecuronium** | Hepatic (60–70%) | Renal (30–40%) | Prolonged effect in hepatic dysfunction | | **Atracurium** | Hofmann elimination (77%) | Ester hydrolysis (23%) | Organ-independent; safe in renal/hepatic failure | | **Cisatracurium** | Hofmann elimination (77%) | Ester hydrolysis (23%) | Organ-independent; preferred in ICU | | **Pancuronium** | Renal (80–90%) | Hepatic (10–20%) | **Most renal-dependent** | | **Rocuronium** | Hepatic (70–80%) | Renal (20–30%) | Prolonged effect in hepatic dysfunction | | **Mivacurium** | Plasma pseudocholinesterase | — | Rapid onset/offset; prolonged in deficiency | | **Doxacurium** | Renal (77%) | Hepatic (23%) | Renal-dependent | ### Why Renal Excretion Is Most Common **High-Yield:** Most non-depolarising muscle relaxants are quaternary ammonium compounds (highly ionized, water-soluble, lipophobic). This chemical structure: 1. Prevents hepatic metabolism (too polar) 2. Prevents plasma protein binding 3. Mandates renal glomerular filtration for elimination ### Clinical Pearl: Organ Dysfunction Impact **Renal failure** → prolonged blockade (pancuronium, doxacurium, atracurium to lesser extent) **Hepatic failure** → prolonged blockade (vecuronium, rocuronium) **Both renal AND hepatic failure** → use organ-independent agents (atracurium, cisatracurium) ### Why Other Options Are Less Common **Hepatic metabolism** — occurs in only 2–3 agents (vecuronium, rocuronium) and is NOT the primary route for most non-depolarisers. **Plasma pseudocholinesterase hydrolysis** — unique to mivacurium only; not applicable to the majority of non-depolarising agents. **Hofmann elimination** — organ-independent but occurs in only 2 agents (atracurium, cisatracurium); NOT the most common route overall. **Mnemonic: REACH** — Renal Excretion is the most common route for non-depolarising Agents; Check Hepatic metabolism in Vecuronium and Rocuronium.